Report of the Working Group 'Overall Blood Supply Strategy with Regard to Variant Creutzfeldt-Jakob Disease (vCJD)'

被引：0

作者：

Seitz, Rainer ^{[1
]}

Beekes, Michael ^{[2
]}

Bluemel, Johannes ^{[1
]}

Burger, Reinhard

von Dewitz, Christian ^{[3
]}

Groener, Albrecht ^{[4
]}

Heiden, Margarethe ^{[1
]}

Kretzschmar, Hans ^{[5
]}

Nuebling, Micha ^{[1
]}

Schlenkrich, Uwe ^{[6
]}

Schottstedt, Volkmar ^{[7
]}

Strobel, Johanna ^{[8
]}

Willkommen, Hannelore ^{[9
]}

von Koenig, Carl-Heinz Wirsing ^{[10
]}

Zerr, Inga ^{[11
]}

机构：

[1] Paul Ehrlich Inst, D-63225 Langen, Germany

[2] Robert Koch Inst, D-1000 Berlin, Germany

[3] State Off Hlth & Social Affairs LaGeSo, Berlin, Germany

[4] CSL Behring, Marburg, Germany

[5] Univ Munich, Inst Neuropathol & Pr Res, Munich, Germany

[6] German Hemophilia Soc DIIG, Hamburg, Germany

[7] Blood Serv German Red Cross W DRK, Hagen, Germany

[8] Fed Minist Hlth, Bonn, Germany

[9] NewLab BioQual GmbH, Regulatory Affairs & Biol Safety Consulting, Erkrath, Germany

[10] HELIOS Clin Ctr, Krefeld, Germany

[11] Univ Clin Ctr, Natl Reference Ctr Surveillance TSE, Gottingen, Germany

来源：

TRANSFUSION MEDICINE AND HEMOTHERAPY | 2009年 / 36卷 / 01期

关键词：

TRANSMISSIBLE SPONGIFORM ENCEPHALOPATHY; PATHOLOGICAL PRION PROTEIN; MONOCLONAL-ANTIBODIES; PRP; 27-30; SCRAPIE; INFECTIVITY; TRANSFUSION; CONVERSION; STRAINS; COMPONENTS;

D O I：

10.1159/000188082

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：79 / 93

页数：15

共 50 条

[31] Creutzfeldt-Jakob disease and blood transfusion: safe or not safe?
Cervenakova, Larisa
TRANSFUSION, 2017, 57 (08) : 1851 - 1853
[32] Magnetoencephalographic Abnormalities in Creutzfeldt-Jakob Disease: A Case Report
Wilenius, Juha
Makela, Jyrki P.
Lyytinen, Jukka
Paetau, Anders
Palomaki, Maarit
Pekkonen, Eero
CASE REPORTS IN NEUROLOGY, 2010, 2 (03): : 122 - 127
[33] Creutzfeldt-Jakob disease and blood transfusion-related risk in 1998
Laperche, S
TRANSFUSION CLINIQUE ET BIOLOGIQUE, 1999, 6 (01) : 67 - 71
[34] Transmission of sporadic Creutzfeldt-Jakob disease by blood transfusion: risk factor or possible biases
Puopolo, Maria
Ladogana, Anna
Vetrugno, Vito
Pocchiari, Maurizio
TRANSFUSION, 2011, 51 (07) : 1556 - 1566
[35] Development of Policy and Strategy for the Control of Creutzfeldt-Jakob Disease in Korea
Choi, Seung-Il
Jeong, Byung-Hoon
Kim, Yong-Sun
EPIDEMIOLOGY AND HEALTH, 2005, 27 (01): : 81 - 89
[36] Population Screening for Variant Creutzfeldt-Jakob Disease Using a Novel Blood Test Diagnostic Accuracy and Feasibility Study
Jackson, Graham S.
Burk-Rafel, Jesse
Edgeworth, Julie Ann
Sicilia, Anita
Abdilahi, Sabah
Korteweg, Justine
Mackey, Jonathan
Thomas, Claire
Wang, Guosu
Schott, Jonathan M.
Mummery, Catherine
Chinnery, Patrick F.
Mead, Simon
Collinge, John
JAMA NEUROLOGY, 2014, 71 (04) : 421 - 428
[37] Universal White Blood Cell Reduction in Europe: Has Transmission of Variant Creutzfeldt-Jakob Disease Been Prevented?
Vamvakas, Eleftherios C.
TRANSFUSION MEDICINE REVIEWS, 2011, 25 (02) : 133 - 144
[38] No Adaptation of the Prion Strain in a Heterozygous Case of Variant Creutzfeldt-Jakob Disease
Boyle, Aileen
Plinston, Chris
Laing, Fraser
Mackenzie, Graeme
Will, Robert G.
Manson, Jean C.
Diack, Abigail B.
EMERGING INFECTIOUS DISEASES, 2020, 26 (06) : 1300 - 1303
[39] Evaluation of a test for its suitability in the diagnosis of variant Creutzfeldt-Jakob disease
Cooper, J. K.
Andrews, N.
Ladhani, K.
Bujaki, E.
Minor, P. D.
VOX SANGUINIS, 2013, 105 (03) : 196 - 204
[40] Correlation between Bioassay and Protein Misfolding Cyclic Amplification for Variant Creutzfeldt-Jakob Disease Decontamination Studies
Belondrade, Maxime
Jas-Duval, Christelle
Nicot, Simon
Bruyere-Ostells, Lilian
Mayran, Charly
Herzog, Laetitia
Reine, Fabienne
Maria Torres, Juan
Fournier-Wirth, Chantal
Beringue, Vincent
Lehmann, Sylvain
Bougard, Daisy
MSPHERE, 2020, 5 (01):

← 1 2 3 4 5 →